title: Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice.
abstract: AT(1) double receptor (AT(1A) and AT(1B)) knockout mice have lower blood pressure, impaired growth, and develop early renal microvascular disease and tubulointerstitial injury. We hypothesized that there would be an increased expression of vasoactive, profibrotic, and inflammatory mediators expressed in the kidneys of AT(1) double-knockout mice. We examined the renal expression of various mediator systems in control (n = 6) vs. double-knockout mice (n = 6) at 3-5 mo of age by real-time PCR, immunohistochemistry, and Western blot analysis. AT(1) double-knockout mice show activation of Th1-dependent pathways (with increased expression of IFN-alpha, IL-2 mRNA) with increased expression of both monocyte (MCP-1 mRNA) and T cell (RANTES mRNA) chemokines, infiltration of CD4(+) and CD11b(+) cells, increased fibrosis-associated mediators (CTGF, TGF-beta and TNF-alpha mRNA) and extracellular matrix (collagens I and III mRNA and protein) deposition compared with controls (P < 0.05 for all markers). These changes were associated with increased mRNA expression of endothelin (ET)-1 and ET-A receptor (P < 0.05), cyclooxygenase (COX)-2/TXA2 synthase (P < 0.05), NADPH oxidase (p40-phox, p67-phox, P < 0.05) and iNOS and nNOS (P < 0.05). COX-2 and nNOS protein were also increased in the kidneys of AT(1) double-knockout mice by Western blot analysis (P < 0.05). Although renin and angiotensinogen mRNA expression were increased in the knockout mice, AT(2) receptor mRNA expression was not significantly different from wild-type mice. In conclusion, the absence of the AT(1) receptor is associated with marked renal alterations in vasoactive, profibrotic, and immune mediators with an inflammatory pattern favoring a Th1 phenotype.
authors.affiliation: Division of Nephrology, Dept. of Medicine, Univ. of Florida, Gainesville, FL 32610, USA. ouyangx@medicine.ufl.edu
authors.forename: Xiaosen
authors.initials: X
authors.lastname: Ouyang
authors.forename: Thu H
authors.initials: TH
authors.lastname: Le
authors.forename: Carlos
authors.initials: C
authors.lastname: Roncal
authors.forename: Christine
authors.initials: C
authors.lastname: Gersch
authors.forename: Jaime
authors.initials: J
authors.lastname: Herrera-Acosta
authors.forename: Bernardo
authors.initials: B
authors.lastname: Rodriguez-Iturbe
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Coffman
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Johnson
authors.forename: Wei
authors.initials: W
authors.lastname: Mu
mesh_terms: D000818:Animals; D015153:Blotting, Western; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000502:physiology; D005355:Fibrosis; D007249:Inflammation / Q000378:metabolism / Q000473:pathology*; D018836:Inflammation Mediators / Q000502:physiology*; D007668:Kidney / Q000378:metabolism / Q000473:pathology*; D008264:Macrophages / Q000502:physiology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D019255:NADPH Oxidases / Q000378:metabolism; D018384:Oxidative Stress / Q000502:physiology; D012313:RNA; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018417:Th1 Cells / Q000502:physiology*
chemical_list: D018836:Inflammation Mediators; C034477:RNA primers; D012313:RNA; D019255:NADPH Oxidases